Tocira 80 mg Injection

Product Details

Tocira 80mg Injection contains tocilizumab, a monoclonal antibody that targets the interleukin-6 (IL-6) receptor, helping to reduce inflammation and immune activity in the body. It is primarily used to treat autoimmune conditions like rheumatoid arthritis and juvenile idiopathic arthritis (JIA). Tocilizumab works by blocking IL-6, a protein that contributes to inflammatory responses, thereby alleviating symptoms such as joint pain, swelling, and damage. Tocira can also be prescribed for cytokine release syndrome (CRS), a severe immune reaction seen with some immunotherapies.

Uses:

• Treatment of moderate to severe rheumatoid arthritis in adults, often combined with other disease-modifying antirheumatic drugs (DMARDs).
• Management of systemic juvenile idiopathic arthritis (SJIA) and polyarticular juvenile idiopathic arthritis (PJIA) in children.
• Used to treat cytokine release syndrome (CRS) related to CAR T-cell therapy.
• May be used for other inflammatory conditions as advised by a healthcare professional.

Side Effects:

• Common side effects: respiratory infections, headaches, increased liver enzymes, high blood pressure, and injection site reactions.
• Serious side effects: increased risk of serious infections (e.g., tuberculosis), liver problems, gastrointestinal perforations, and allergic reactions. Immediate medical attention is recommended if severe or unusual symptoms arise.

Key Features:

• Contains tocilizumab, a monoclonal antibody that targets and blocks IL-6 activity.
• Reduces inflammation and immune overactivity, providing relief for autoimmune diseases.
• Administered via injection, suitable for rheumatoid arthritis, juvenile arthritis, and cytokine release syndrome.
• Proven efficacy in reducing symptoms and disease progression in autoimmune disorders.

FAQ:

1. How does Tocira 80mg Injection work?
   Tocira blocks the interleukin-6 (IL-6) receptor, which is involved in inflammatory and immune responses. By inhibiting IL-6, it helps reduce inflammation and immune overactivity.
2. Who can use Tocira?
   Tocira is prescribed for adults with rheumatoid arthritis and children with juvenile idiopathic arthritis, among other inflammatory conditions, as determined by a healthcare provider.
3. What precautions should I take while using Tocira?
   Regular monitoring for infections, liver function, and blood counts is crucial. Notify your healthcare provider of any underlying conditions, such as liver disease or a history of infections.

References:

1. Roche Pharmaceuticals. “Actemra (tocilizumab) Injection.” [Accessed on 6 Nov 2024]. Available from: https://www.drugs.com/actemra.html
2. European Medicines Agency (EMA). “Tocilizumab Product Information.” [Accessed on 6 Nov 2024]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK570644/